Ozempic
- Product NDC
- 50090-8027
- 11-digit product format
- 500908027
- Labeler code
- 50090
- Product ID
- 50090-8027_4b9bdfa7-1075-45cd-baac-66632beb38df
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- semaglutide
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Labeler
- A-S Medication Solutions
- Application
- NDA209637
- Marketing category
- NDA
- Marketing start
- 2022-10-07
- Substance
- SEMAGLUTIDE
- Active strength
- .68 mg/mL
- Pharmacologic classes
- GLP-1 Receptor Agonist [EPC]; Glucagon-Like Peptide 1 [CS]; Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N209637-001 | OZEMPIC | SEMAGLUTIDE | 2MG/1.5ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD | 2017-12-05 | |
| N209637-002 | OZEMPIC | SEMAGLUTIDE | 4MG/3ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2019-04-09 | |
| N209637-003 | OZEMPIC | SEMAGLUTIDE | 8MG/3ML (2.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-03-28 | |
| N209637-004 | OZEMPIC | SEMAGLUTIDE | 2MG/3ML (0.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-10-06 | |
| N209637-005 | OZEMPIC | SEMAGLUTIDE | 0.25MG/0.5ML (0.25MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2026-05-05 | |
| N209637-006 | OZEMPIC | SEMAGLUTIDE | 0.5MG/0.5ML (0.5MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2026-05-05 | |
| N209637-007 | OZEMPIC | SEMAGLUTIDE | 1MG/0.5ML (1MG/0.5ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2026-05-05 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N209637-001 | 10357616 | 2026-01-20 | Drug product, Delist requested | 2019-08-08 | |
| N209637-001 | 10376652 | 2026-01-20 | Drug product, Delist requested | 2019-09-13 | |
| N209637-001 | 9108002 | 2026-01-20 | Drug product, Delist requested | 2017-12-20 | |
| N209637-001 | 9616180 | 2026-01-20 | Drug product, Delist requested | 2018-08-17 | |
| N209637-001 | 9861757 | 2026-01-20 | Drug product, Delist requested | 2018-08-17 | |
| N209637-001 | 8536122 | 2026-03-20 | U-2202 | Drug substance, Drug product | 2017-12-20 |
| N209637-001 | 10220155 | 2026-07-17 | Drug product, Delist requested | 2019-04-04 | |
| N209637-001 | 11097063 | 2026-07-17 | Drug product, Delist requested | 2021-09-21 | |
| N209637-001 | 8920383 | 2026-07-17 | Drug product, Delist requested | 2017-12-20 | |
| N209637-001 | 9775953 | 2026-07-17 | Drug product, Delist requested | 2017-12-20 | |
| N209637-001 | RE46363 | 2026-08-03 | Drug product, Delist requested | 2017-12-20 | |
| N209637-001 | 9687611 | 2027-02-27 | Drug product, Delist requested | 2017-12-20 | |
| N209637-001 | 9457154 | 2027-09-29 | Drug product, Delist requested | 2017-12-20 | |
| N209637-001 | 8129343 | 2031-12-05 | U-2202 | Drug substance, Drug product | 2017-12-20 |
| N209637-001 | 9132239 | 2032-02-01 | Drug product, Delist requested | 2017-12-20 | |
| N209637-001 | 10335462 | 2033-06-21 | U-2580 | 2019-07-25 | |
| N209637-002 | 10357616 | 2026-01-20 | Drug product, Delist requested | 2020-12-21 | |
| N209637-002 | 10376652 | 2026-01-20 | Drug product, Delist requested | 2020-12-21 | |
| N209637-002 | 9108002 | 2026-01-20 | Drug product, Delist requested | 2020-12-21 | |
| N209637-002 | 9616180 | 2026-01-20 | Drug product, Delist requested | 2020-12-21 | |
| N209637-002 | 9861757 | 2026-01-20 | Drug product, Delist requested | 2020-12-21 | |
| N209637-002 | 8536122 | 2026-03-20 | U-2202 | Drug substance, Drug product | 2020-09-24 |
| N209637-002 | 10220155 | 2026-07-17 | Drug product, Delist requested | 2020-12-21 | |
| N209637-002 | 11097063 | 2026-07-17 | Drug product, Delist requested | 2021-09-21 | |
| N209637-002 | 8920383 | 2026-07-17 | Drug product, Delist requested | 2020-12-21 | |
| N209637-002 | 9775953 | 2026-07-17 | Drug product, Delist requested | 2020-12-21 | |
| N209637-002 | RE46363 | 2026-08-03 | Drug product, Delist requested | 2020-12-21 | |
| N209637-002 | 9687611 | 2027-02-27 | Drug product, Delist requested | 2020-12-21 | |
| N209637-002 | 9457154 | 2027-09-29 | Drug product, Delist requested | 2020-12-21 | |
| N209637-002 | 8129343 | 2031-12-05 | U-2202 | Drug substance, Drug product | 2020-09-24 |
| N209637-002 | 9132239 | 2032-02-01 | Drug product, Delist requested | 2020-12-21 | |
| N209637-002 | 10335462 | 2033-06-21 | U-2580 | 2020-09-24 | |
| N209637-002 | 12569543 | 2037-04-28 | U-4446 | 2026-03-31 | |
| N209637-002 | 12295988 | 2038-10-10 | U-1852 | 2026-06-23 | |
| N209637-003 | 10357616 | 2026-01-20 | Drug product, Delist requested | 2022-04-29 | |
| N209637-003 | 10376652 | 2026-01-20 | Drug product, Delist requested | 2022-04-29 | |
| N209637-003 | 9108002 | 2026-01-20 | Drug product, Delist requested | 2022-04-29 | |
| N209637-003 | 9616180 | 2026-01-20 | Drug product, Delist requested | 2022-04-29 | |
| N209637-003 | 9861757 | 2026-01-20 | Drug product, Delist requested | 2022-04-29 | |
| N209637-003 | 8536122 | 2026-03-20 | U-3355 | Drug substance, Drug product | 2022-04-29 |
| N209637-003 | 10220155 | 2026-07-17 | Drug product, Delist requested | 2022-04-29 | |
| N209637-003 | 11097063 | 2026-07-17 | Drug product, Delist requested | 2022-04-29 | |
| N209637-003 | 8920383 | 2026-07-17 | Drug product, Delist requested | 2022-04-29 | |
| N209637-003 | 9775953 | 2026-07-17 | Drug product, Delist requested | 2022-04-29 | |
| N209637-003 | RE46363 | 2026-08-03 | Drug product, Delist requested | 2022-04-29 | |
| N209637-003 | 9687611 | 2027-02-27 | Drug product, Delist requested | 2022-04-29 | |
| N209637-003 | 9457154 | 2027-09-29 | Drug product, Delist requested | 2022-04-29 | |
| N209637-003 | 8129343 | 2031-12-05 | U-3355 | Drug substance, Drug product | 2022-04-29 |
| N209637-003 | 9132239 | 2032-02-01 | Drug product, Delist requested | 2022-04-29 | |
| N209637-003 | 12569543 | 2037-04-28 | U-4446 | 2026-03-31 | |
| N209637-003 | 12295988 | 2038-10-10 | U-2628 | 2025-05-29 | |
| N209637-004 | 10357616 | 2026-01-20 | Drug product, Delist requested | 2022-11-14 | |
| N209637-004 | 10376652 | 2026-01-20 | Drug product, Delist requested | 2022-11-14 | |
| N209637-004 | 9108002 | 2026-01-20 | Drug product, Delist requested | 2022-11-14 | |
| N209637-004 | 9616180 | 2026-01-20 | Drug product, Delist requested | 2022-11-14 | |
| N209637-004 | 9861757 | 2026-01-20 | Drug product, Delist requested | 2022-11-14 | |
| N209637-004 | 8536122 | 2026-03-20 | U-3469 | Drug substance, Drug product | 2022-11-14 |
| N209637-004 | 10220155 | 2026-07-17 | Drug product, Delist requested | 2022-11-14 | |
| N209637-004 | 11097063 | 2026-07-17 | Drug product, Delist requested | 2022-11-14 | |
| N209637-004 | 8920383 | 2026-07-17 | Drug product, Delist requested | 2022-11-14 | |
| N209637-004 | 9775953 | 2026-07-17 | Drug product, Delist requested | 2022-11-14 | |
| N209637-004 | RE46363 | 2026-08-03 | Drug product, Delist requested | 2022-11-14 | |
| N209637-004 | 9687611 | 2027-02-27 | Drug product, Delist requested | 2022-11-14 | |
| N209637-004 | 9457154 | 2027-09-29 | Drug product, Delist requested | 2022-11-14 | |
| N209637-004 | 8129343 | 2031-12-05 | U-3469 | Drug substance, Drug product | 2022-11-14 |
| N209637-004 | 9132239 | 2032-02-01 | Drug product, Delist requested | 2022-11-14 | |
| N209637-004 | 10335462 | 2033-06-21 | U-2580 | Drug product | 2022-11-14 |
| N209637-004 | 12569543 | 2037-04-28 | U-4446 | 2026-03-31 | |
| N209637-004 | 12295988 | 2038-10-10 | U-1852 | 2026-06-23 | |
| N209637-005 | 8129343 | 2031-12-05 | U-3355 | Drug substance, Drug product | 2026-06-23 |
| N209637-005 | 12569543 | 2037-04-28 | U-4446 | 2026-06-23 | |
| N209637-005 | 10888605 | 2038-08-24 | U-1852 | Drug product | 2026-06-23 |
| N209637-005 | 11752198 | 2038-08-24 | U-1852 | Drug product | 2026-06-23 |
| N209637-005 | 12214017 | 2038-08-24 | U-1852 | Drug product | 2026-06-23 |
| N209637-005 | 11318191 | 2041-02-17 | U-1852 | Drug product | 2026-06-23 |
| N209637-005 | 11318191 | 2041-02-17 | U-4561 | Drug product | 2026-06-23 |
| N209637-006 | 8129343 | 2031-12-05 | U-3355 | Drug substance, Drug product | 2026-06-23 |
| N209637-006 | 12569543 | 2037-04-28 | U-4446 | 2026-06-23 | |
| N209637-006 | 10888605 | 2038-08-24 | U-1852 | Drug product | 2026-06-23 |
| N209637-006 | 11752198 | 2038-08-24 | U-1852 | Drug product | 2026-06-23 |
Orange Book exclusivity#
| Application-product | Exclusivity code | Expiration |
|---|---|---|
| N209637-001 | I-961 | 2028-01-28 |
| N209637-002 | I-961 | 2028-01-28 |
| N209637-003 | I-961 | 2028-01-28 |
| N209637-004 | I-961 | 2028-01-28 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N209637-001 | OZEMPIC | 2MG/1.5ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD | 2017-12-05 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209637-002 | OZEMPIC | 4MG/3ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2019-04-09 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209637-003 | OZEMPIC | 8MG/3ML (2.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-03-28 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209637-004 | OZEMPIC | 2MG/3ML (0.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-10-06 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N209637-001 | OZEMPIC | 2MG/1.5ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD | 2017-12-05 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N209637-002 | OZEMPIC | 4MG/3ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2019-04-09 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N209637-003 | OZEMPIC | 8MG/3ML (2.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-03-28 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N209637-004 | OZEMPIC | 2MG/3ML (0.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-10-06 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N209637-001 | OZEMPIC | 2MG/1.5ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2017-12-05 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N209637-002 | OZEMPIC | 4MG/3ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2019-04-09 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N209637-003 | OZEMPIC | 8MG/3ML (2.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-03-28 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N209637-004 | OZEMPIC | 2MG/3ML (0.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-10-06 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N209637-001 | OZEMPIC | 2MG/1.5ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2017-12-05 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N209637-002 | OZEMPIC | 4MG/3ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2019-04-09 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N209637-003 | OZEMPIC | 8MG/3ML (2.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-03-28 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N209637-004 | OZEMPIC | 2MG/3ML (0.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-10-06 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N209637-001 | OZEMPIC | 2MG/1.5ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2017-12-05 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N209637-002 | OZEMPIC | 4MG/3ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2019-04-09 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N209637-003 | OZEMPIC | 8MG/3ML (2.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-03-28 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N209637-004 | OZEMPIC | 2MG/3ML (0.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-10-06 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N209637-001 | OZEMPIC | 2MG/1.5ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2017-12-05 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N209637-002 | OZEMPIC | 4MG/3ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2019-04-09 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N209637-003 | OZEMPIC | 8MG/3ML (2.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-03-28 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N209637-004 | OZEMPIC | 2MG/3ML (0.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-10-06 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N209637-001 | OZEMPIC | 2MG/1.5ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2017-12-05 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N209637-002 | OZEMPIC | 4MG/3ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2019-04-09 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N209637-003 | OZEMPIC | 8MG/3ML (2.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-03-28 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N209637-004 | OZEMPIC | 2MG/3ML (0.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-10-06 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N209637-001 | OZEMPIC | 2MG/1.5ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2017-12-05 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N209637-002 | OZEMPIC | 4MG/3ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2019-04-09 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N209637-003 | OZEMPIC | 8MG/3ML (2.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-03-28 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N209637-004 | OZEMPIC | 2MG/3ML (0.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-10-06 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N209637-001 | OZEMPIC | 2MG/1.5ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2017-12-05 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N209637-002 | OZEMPIC | 4MG/3ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2019-04-09 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N209637-003 | OZEMPIC | 8MG/3ML (2.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-03-28 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N209637-004 | OZEMPIC | 2MG/3ML (0.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-10-06 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N209637-001 | OZEMPIC | 2MG/1.5ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2017-12-05 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N209637-002 | OZEMPIC | 4MG/3ML (1.34MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2019-04-09 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N209637-003 | OZEMPIC | 8MG/3ML (2.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-03-28 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N209637-004 | OZEMPIC | 2MG/3ML (0.68MG/ML) | SOLUTION / SUBCUTANEOUS | RLD, RS | 2022-10-06 | d06236e962d9… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N209637-001 | 10357616 | 2026-01-20 | Drug product, Delist requested | 2019-08-08 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209637-001 | 10376652 | 2026-01-20 | Drug product, Delist requested | 2019-09-13 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209637-001 | 9108002 | 2026-01-20 | Drug product, Delist requested | 2017-12-20 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209637-001 | 9616180 | 2026-01-20 | Drug product, Delist requested | 2018-08-17 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209637-001 | 9861757 | 2026-01-20 | Drug product, Delist requested | 2018-08-17 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209637-001 | 8536122 | 2026-03-20 | U-2202 | Drug substance, Drug product | 2017-12-20 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N209637-001 | 10220155 | 2026-07-17 | Drug product, Delist requested | 2019-04-04 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209637-001 | 11097063 | 2026-07-17 | Drug product, Delist requested | 2021-09-21 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209637-001 | 8920383 | 2026-07-17 | Drug product, Delist requested | 2017-12-20 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209637-001 | 9775953 | 2026-07-17 | Drug product, Delist requested | 2017-12-20 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209637-001 | RE46363 | 2026-08-03 | Drug product, Delist requested | 2017-12-20 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209637-001 | 9687611 | 2027-02-27 | Drug product, Delist requested | 2017-12-20 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209637-001 | 9457154 | 2027-09-27 | Drug product, Delist requested | 2017-12-20 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209637-001 | 8129343 | 2031-12-05 | U-2202 | Drug substance, Drug product | 2017-12-20 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N209637-001 | 9132239 | 2032-02-01 | Drug product, Delist requested | 2017-12-20 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209637-001 | 10335462 | 2033-06-21 | U-2580 | 2019-07-25 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209637-002 | 10357616 | 2026-01-20 | Drug product, Delist requested | 2020-12-21 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209637-002 | 10376652 | 2026-01-20 | Drug product, Delist requested | 2020-12-21 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209637-002 | 9108002 | 2026-01-20 | Drug product, Delist requested | 2020-12-21 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209637-002 | 9616180 | 2026-01-20 | Drug product, Delist requested | 2020-12-21 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209637-002 | 9861757 | 2026-01-20 | Drug product, Delist requested | 2020-12-21 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209637-002 | 8536122 | 2026-03-20 | U-2202 | Drug substance, Drug product | 2020-09-24 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N209637-002 | 10220155 | 2026-07-17 | Drug product, Delist requested | 2020-12-21 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209637-002 | 11097063 | 2026-07-17 | Drug product, Delist requested | 2021-09-21 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209637-002 | 8920383 | 2026-07-17 | Drug product, Delist requested | 2020-12-21 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209637-002 | 9775953 | 2026-07-17 | Drug product, Delist requested | 2020-12-21 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209637-002 | RE46363 | 2026-08-03 | Drug product, Delist requested | 2020-12-21 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209637-002 | 9687611 | 2027-02-27 | Drug product, Delist requested | 2020-12-21 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209637-002 | 9457154 | 2027-09-29 | Drug product, Delist requested | 2020-12-21 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209637-002 | 8129343 | 2031-12-05 | U-2202 | Drug substance, Drug product | 2020-09-24 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N209637-002 | 9132239 | 2032-02-01 | Drug product, Delist requested | 2020-12-21 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209637-002 | 10335462 | 2033-06-21 | U-2580 | 2020-09-24 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209637-003 | 10357616 | 2026-01-20 | Drug product, Delist requested | 2022-04-29 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209637-003 | 10376652 | 2026-01-20 | Drug product, Delist requested | 2022-04-29 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209637-003 | 9108002 | 2026-01-20 | Drug product, Delist requested | 2022-04-29 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209637-003 | 9616180 | 2026-01-20 | Drug product, Delist requested | 2022-04-29 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209637-003 | 9861757 | 2026-01-20 | Drug product, Delist requested | 2022-04-29 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209637-003 | 8536122 | 2026-03-20 | U-3355 | Drug substance, Drug product | 2022-04-29 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N209637-003 | 10220155 | 2026-07-17 | Drug product, Delist requested | 2022-04-29 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N209637-003 | 11097063 | 2026-07-17 | Drug product, Delist requested | 2022-04-29 | 011fe1cb6892… |
Observed Orange Book exclusivity history#
| Captured | Edition | Application-product | Exclusivity code | Expiration | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N209637-001 | I-961 | 2028-01-28 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N209637-002 | I-961 | 2028-01-28 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N209637-003 | I-961 | 2028-01-28 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N209637-004 | I-961 | 2028-01-28 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N209637-001 | I-961 | 2028-01-28 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N209637-002 | I-961 | 2028-01-28 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N209637-003 | D-185 | 2025-03-28 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N209637-003 | I-961 | 2028-01-28 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N209637-004 | I-961 | 2028-01-28 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N209637-001 | I-961 | 2028-01-28 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N209637-002 | I-961 | 2028-01-28 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N209637-003 | D-185 | 2025-03-28 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N209637-003 | I-961 | 2028-01-28 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N209637-004 | I-961 | 2028-01-28 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N209637-001 | I-961 | 2028-01-28 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N209637-002 | I-961 | 2028-01-28 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N209637-003 | D-185 | 2025-03-28 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N209637-003 | I-961 | 2028-01-28 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N209637-004 | I-961 | 2028-01-28 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N209637-003 | D-185 | 2025-03-28 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N209637-003 | D-185 | 2025-03-28 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N209637-003 | D-185 | 2025-03-28 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N209637-003 | D-185 | 2025-03-28 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N209637-003 | D-185 | 2025-03-28 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N209637-003 | D-185 | 2025-03-28 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N209637-003 | D-185 | 2025-03-28 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N209637-003 | D-185 | 2025-03-28 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N209637-003 | D-185 | 2025-03-28 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | N209637-003 | D-185 | 2025-03-28 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N209637-001 | NCE | 2022-12-05 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N209637-001 | I-822 | 2023-01-16 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N209637-002 | NCE | 2022-12-05 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N209637-002 | I-822 | 2023-01-16 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N209637-003 | NCE | 2022-12-05 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N209637-003 | D-185 | 2025-03-28 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | N209637-001 | NCE | 2022-12-05 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | N209637-001 | I-822 | 2023-01-16 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | N209637-002 | NCE | 2022-12-05 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | N209637-002 | I-822 | 2023-01-16 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | N209637-001 | NCE | 2022-12-05 | 4b0b4de00fa7… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Ozempic
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| SEMAGLUTIDE | .68 mg/mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 53AXN4NNHX | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 42bdd912-2393-44c4-b7e0-47672ca28991 | Available on FDA.report |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ozempic | SEMAGLUTIDE | A-S Medication Solutions | 42bdd912-2393-44c4-b7e0-47672ca28991 | 2026-07-30 | Boxed warning, Warnings, Adverse reactions | 209637 NDA209637 50090-8027 |
| Ozempic | SEMAGLUTIDE | A-S Medication Solutions | 979e4df4-0597-48ea-b51c-0f699fa6d166 | 2023-11-22 | Boxed warning, Warnings, Adverse reactions | 209637 NDA209637 |
| OZEMPIC | SEMAGLUTIDE | A-S Medication Solutions | e6da837c-0da0-41d6-973c-5559bf764367 | 2023-11-17 | Boxed warning, Warnings, Adverse reactions | 209637 NDA209637 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Sample | Status |
|---|---|---|---|---|---|
| 50090-8027-0 | 50090802700 | 1 SYRINGE, PLASTIC in 1 CARTON (50090-8027-0) / 3 mL in 1 SYRINGE, PLASTIC | 2026-07-29 | 0 | Current |